Vblt stock price
VBLT / Vascular Biogenics Ltd. - Institutional Ownership and Shareholders File Date, Form, Investor, Opt, Avg Share Price, Shares, Shares Changed Stocks that are quantitatively similar to CCXI, based on their financial statements, market capitalization, and price volatility, are BPMC, CKPT, VBLT, DRNA, and Stocks with similar financial metrics, market capitalization, and price volatility to Ardelyx Inc are OTIC, VBLT, ATHX, CKPT, and XLRN. Visit ARDX's SEC page to 26 Mar 2020 VBLT VBL Therapeutics. $1.37 /. +0.22 (+19.13%). 11/14/19 Chardan: VBL Therapeutics upgraded to Buy with $3.25 price target at Chardan.
Vascular Biogen. Ord (VBLT) [[ item.lastPrice ]] [[ item.priceChange ]] It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share.
Apr 04, 2020 · Vascular Biogenics (NASDAQ:VBLT) ‘s stock had its “buy” rating restated by research analysts at Chardan Capital in a note issued to investors on Friday, TipRanks reports. They currently have a $5.00 price objective on the biopharmaceutical company’s stock. Chardan Capital’s target price indicates a potential upside of 331.03% from the stock’s current price. HC Wainwright Reaffirms “Buy” Rating for Vascular ... Apr 08, 2020 · HC Wainwright reaffirmed their buy rating on shares of Vascular Biogenics (NASDAQ:VBLT) in a report published on Sunday, AnalystRatings.com reports. The firm currently has a $3.00 price target on the biopharmaceutical company’s stock. VBLT has been the topic of a number of other research reports. Zacks Investment Research cut shares of Vascular Biogenics from a […] Vascular Biogenics (NASDAQ:VBLT) Stock Rating Reaffirmed ... Vascular Biogenics (NASDAQ:VBLT)‘s stock had its “buy” rating reaffirmed by equities research analysts at HC Wainwright in a research report issued to clients and investors on Sunday, AnalystRatings.com reports. They currently have a $3.00 target price on the biopharmaceutical company’s stock. Vascular Biogenics: A Buy On Promising Cancer Therapy ... Apr 01, 2020 · If results of Phase 3 trial are positive in late 2022, stock price should rise sharply. Vascular Biogenics (NASDAQ: VBLT ), which operates as VBL Therapeutics, is a clinical stage pharmaceutical
Stocks that are quantitatively similar to CCXI, based on their financial statements, market capitalization, and price volatility, are BPMC, CKPT, VBLT, DRNA, and
Nov 05, 2019 · Vascular Biogenics Ltd. company facts, information and stock details by MarketWatch. View vblt business summary and other industry information. VBLT Stock | VASCULAR BIOGENICS Stock Price Today ...
View the real-time VBLT price chart on Robinhood and decide if you want to buy or sell commission-free. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Vascular Biogenics against related stocks people have also bought like OGEN, CHK, IGC, and GERN. 763 people own Vascular Biogenics on Robinhood on April 4, 2020.
Vascular Biogenics Ltd., VBLT Quick Chart - (NAS) VBLT ... VBLT - Vascular Biogenics Ltd. Basic Chart, Quote and financial news from the leading provider and award-winning BigCharts.com. 1 day 2 days 5 days 10 days ---------- 1 month 2 months 3 months 6 months YTD 1 year 2 years 3 years 4 years 5 years 1 decade All Data Basic Chart Advanced Chart VBLT - Vascular Biogen. Ord Stock Profile - Barchart.com Company profile for Vascular Biogen. Ord (VBLT) including business summary, key statistics, ratios, sector. then divides by the last fiscal year net equity per share of common stock. Price/Sales - Latest closing price of the stock divided by the last twelve months revenue/sales per share. VASCULAR BIOGENICS LTD. : VBLT Stock Price | IL0011327454 ... Vascular Biogenics Ltd. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of treatments for cancer.
Get breaking news and analysis on Vascular Biogenics Ltd. (VBLT) stock, price quote and chart, trading and investing tools. Get breaking news and analysis on Vascular Biogenics Ltd. (VBLT) stock
Stocks that are quantitatively similar to CCXI, based on their financial statements, market capitalization, and price volatility, are BPMC, CKPT, VBLT, DRNA, and
VBLT's NASDAQ Last Sale (NLS) "Last Sale" is the price at which a stock last traded during regular market hours. NLS Volume "Volume" is the number of shares of the stock traded on the listing exchange during regular trading hours. Previous Close Today's High / Low 52 Week High / Low